Clinical trials
Asthma clinical trials
A condition where the airways narrow and swell, making breathing difficult. We’re tracking 385 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06392776Recruiting
Finding untreated asthma or COPD early
This study aims to find people with undiagnosed asthma or COPD by using a simple questionnaire and a breathing test. If you have symptoms like cough or wheeze but no prior diagnosis, you may be able to join and get early treatment.
Hamilton, OntarioAges 18 years+ - NCT06372249RecruitingPhase 2
Fiber drink for asthma in kids
This trial tests whether a liquid fiber drink can help children with asthma by reducing airway inflammation. Participants will drink either fiber or a placebo and be followed for about 4–6 weeks to see if their asthma improves.
Phoenix, ArizonaAges 6–17 - NCT06323213RecruitingPhase 3
Testing a new asthma medicine for severe asthma
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06317909Recruiting
New test for airway inflammation after allergen challenge in mild asthma
This study tests a new, non-invasive way to measure airway inflammation after breathing in an allergen (like pollen or dust mite). It is for people with mild asthma that is well controlled with only a rescue inhaler.
Hanover, Lower SaxonyAges 18–65 - NCT06307665RecruitingPhase 3
Asthma study for teens comparing two inhalers
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
Anchorage, AlaskaAges 12–17 - NCT06299592Recruiting
Brain inflammation in severe asthma vs. healthy adults
This study uses brain scans to compare inflammation in the brain between people with severe asthma and healthy volunteers. It aims to understand how asthma may affect the brain.
Madison, WisconsinAges 18–75 - NCT06286085Recruiting
Comparing asthma tests in Portsmouth
This study looks at different ways to test for asthma. It uses data from patients who have already been evaluated at the Portsmouth asthma service, to see which tests work best for diagnosing asthma.
PortsmouthAges 18 years+ - NCT06216535RecruitingPhase 2
Escitalopram for frequent asthma attacks
This study tests whether the antidepressant escitalopram can reduce asthma attacks in people who have frequent, severe flare-ups despite using their regular inhalers. It may help if you have moderate to severe asthma and have had 3 or more attacks needing steroids in the past year.
Dallas, TexasAges 18–75 - NCT06223828RecruitingPhase 2/Phase 3
Azithromycin for Children with Severe Asthma in the ICU
This trial tests whether adding the antibiotic azithromycin to standard asthma treatments helps children with severe asthma in the pediatric intensive care unit (PICU) recover faster. It is for children ages 3 to 17 who are already receiving strong asthma medicines and steroids.
St. Petersburg, FloridaAges 3–17 - NCT06191315Enrolling by invitationPhase 3
Dupilumab for asthma and wheezing in young children
This study tests if the medicine Dupilumab can help control asthma and wheezing in children ages 2 to just under 6. It is for children whose symptoms are not well-managed with their current inhaler.
Phoenix, ArizonaAges 2–5 - NCT06196034Recruiting
Genetic study of asthma severity and types
This study looks at how genes are linked to different types and severities of asthma. It aims to understand why asthma affects people differently, which could lead to better treatments.
Hong Kong, New TerritoriesAges 18–100 - NCT06159127Recruiting
SMART@Home: A smartphone program for teens with chronic conditions
This trial is testing a new program called SMART@Home that helps teens manage their long-term health conditions using a smartphone app. It aims to see if this approach is practical and helpful for teens with conditions like asthma.
Cincinnati, OhioAges 12–18 - NCT06163807Recruiting
Asthma and nasal polyps long-term observation study
This study follows people with asthma (with or without nasal polyps) to learn more about how the disease changes over time. If you already take part in the MEGA cohort or use a biologic drug for severe asthma, this may be a way to contribute to research while continuing your normal care.
Santiago de Compostela, AcoruñaAges 18–80 - NCT06023589RecruitingPhase 3
Testing tezepelumab for kids with severe asthma
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
Montgomery, AlabamaAges 5–11 - NCT05999032Recruiting
Puerto Rico Asthma Integrated Response Program for children
This study tests a program to help children aged 2 to 12 with asthma that is not well controlled. The program provides support and resources to improve asthma management at home.
Providence, Rhode IslandAges 2–12 - NCT05667701RecruitingPhase 2
Soy supplement for babies at high risk of asthma
This Phase 2 study tests whether daily soy isoflavones can lower the chance of asthma or wheezing problems in babies who are at high risk. You would join because your baby has risk factors (family history and certain genetics) and receives the study soy product.
Chicago, IllinoisAges 2 months–1 year - NCT05903001Recruiting
Breathing muscle testing to help track lung disease
This study checks whether measurements of your breathing muscle (the diaphragm) can act as a useful “biomarker” to track lung disease. You might be asked to do breathing tests and follow study instructions, and your results may help researchers better monitor COPD, asthma, fibrosis, or pulmonary hypertension.
Aachen, North Rhine-WestphaliaAges 18 years+ - NCT05819944Recruiting
LUNG-TECH trial testing new tools to diagnose asthma
This trial studies new technologies to help doctors diagnose asthma and better understand airway inflammation. It may help you (or healthy volunteers, if eligible) by allowing your breathing tests and inflammation markers to be measured with newer diagnostic tools.
Portsmouth, HampshireAges 17 years+ - NCT05757102RecruitingPhase 3
Test new inhaler combo versus standard inhaler in teens
This Phase 3 trial compares a triple inhaler (FF/UMEC/VI) against the usual double inhaler (FF/VI) to help control asthma symptoms and breathing tests in teens ages 12–17. It also checks how safe and tolerable the treatments are over the study period.
Birmingham, AlabamaAges 12–17 - NCT05562466RecruitingPhase 3
Tested inhaler for children with asthma ages 6–11
This Phase 3 study compares a new inhaler (QMF149: indacaterol plus mometasone) against budesonide to see which works better and is safe for children ages 6 to under 12 with asthma. You may be able to join if your child is already on a stable low-dose steroid inhaler and still has symptoms.
CABA, Buenos AiresAges 6–11 - NCT05525169Recruiting
Study how indoor and outdoor pollution affects asthma
This study looks at whether exposure to air pollution inside and outside your home affects asthma symptoms and flare-ups. You may be asked to use sensors at home to measure pollution levels and link them to your asthma over time.
NantesAges 18–99 - NCT05445583Recruiting
Technology support program for young adults with uncontrolled asthma
This study tests whether a technology-based program can help improve asthma control in young African American adults who are not currently well controlled. It may help you track symptoms and use asthma tools more consistently between clinic visits.
Tallahassee, FloridaAges 18–30 - NCT05364957Recruiting
Gastric balloon plus asthma care for uncontrolled asthma and obesity
This study tests whether placing a soft “balloon” inside the stomach (intragastric balloon) can help people who have uncontrolled asthma and obesity. It also checks whether the balloon is safe and can improve asthma control when standard inhaler treatment is already in use.
Toulouse, OccitanieAges 18–65 - NCT05341726Recruiting
Test a program to improve asthma control in Black adults
This study tests an approach that combines education and support to help adults with uncontrolled asthma manage their symptoms better and use treatments correctly. It focuses on Black adults receiving care at specific community health clinics.
Beacon, New YorkAges 18 years+
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for asthma?
- Yes. Clin2 currently lists 385 recruiting asthma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a asthma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a asthma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.